Q2 2023 EPS Estimates for Liquidia Co. Reduced by Wedbush (NASDAQ:LQDA)

Liquidia Co. (NASDAQ:LQDA – Get Rating) – Wedbush reduced their Q2 2023 earnings per share (EPS) estimates for Liquidia in a research note issued on Tuesday, May 9th. Wedbush analyst A. Argyrides now expects that the company will earn ($0.17) per share for the quarter, down from their previous estimate of ($0.16). The consensus estimate for Liquidia’s current full-year earnings is ($0.72) per share. Wedbush also issued estimates for Liquidia’s Q3 2023 earnings at ($0.18) EPS, Q4 2023 earnings at ($0.19) EPS, Q4 2023 earnings at ($0.19) EPS, FY2023 earnings at ($0.73) EPS, FY2024 earnings at ($1.20) EPS, FY2025 earnings at ($1.60) EPS, FY2026 earnings at ($1.67) EPS and FY2027 earnings at ($1.63) EPS.

Liquidia (NASDAQ:LQDA – Get Rating) last released its quarterly earnings results on Thursday, March 16th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.17) by $0.08. The business had revenue of $5.36 million during the quarter, compared to the consensus estimate of $3.65 million.

Separately, Needham & Company LLC reaffirmed a “buy” rating and set a $18.00 target price on shares of Liquidia in a research note on Wednesday, April 19th. One investment analyst has rated the stock with a sell rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Liquidia presently has an average rating of “Moderate Buy” and an average price target of $13.60.

Liquidia Stock Down 2.8 %

Shares of LQDA stock opened at $7.26 on Thursday. The stock has a 50-day simple moving average of $6.92 and a 200 day simple moving average of $6.35. Liquidia has a fifty-two week low of $3.26 and a fifty-two week high of $8.79. The stock has a market capitalization of $469.85 million, a P/E ratio of -12.96 and a beta of 0.09.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of LQDA. Caligan Partners LP purchased a new stake in shares of Liquidia during the fourth quarter valued at $64,825,000. State Street Corp lifted its holdings in shares of Liquidia by 861.0% during the second quarter. State Street Corp now owns 1,448,211 shares of the company’s stock valued at $6,314,000 after purchasing an additional 1,297,509 shares during the last quarter. Pura Vida Investments LLC lifted its holdings in shares of Liquidia by 329.2% during the third quarter. Pura Vida Investments LLC now owns 537,870 shares of the company’s stock valued at $2,926,000 after purchasing an additional 772,570 shares during the last quarter. Two Sigma Advisers LP lifted its holdings in shares of Liquidia by 105.5% during the third quarter. Two Sigma Advisers LP now owns 917,700 shares of the company’s stock valued at $4,992,000 after purchasing an additional 471,100 shares during the last quarter. Finally, Northern Trust Corp lifted its holdings in shares of Liquidia by 468.4% during the second quarter. Northern Trust Corp now owns 408,701 shares of the company’s stock valued at $1,782,000 after purchasing an additional 336,794 shares during the last quarter. Institutional investors own 32.64% of the company’s stock.

About Liquidia

(Get Rating)

Liquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. It engages in novel products development used in PRINT technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies.